China Life Insurance Stock Revenue
| 601628 Stock | 41.77 2.41 5.45% |
China Life Insurance fundamentals help investors to digest information that contributes to China Life's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Life stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 829.3 B | 702.3 B |
China | Revenue |
China Life Insurance Company Revenue Analysis
China Life's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current China Life Revenue | 829.26 B |
Most of China Life's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Life Insurance is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of China
Projected quarterly revenue analysis of China Life Insurance provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of China Life match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in China Life's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
China Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, China Life Insurance reported 829.26 B of revenue. This is much higher than that of the Insurance sector and significantly higher than that of the Financials industry. The revenue for all China stocks is significantly lower than that of the firm.
China Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Life's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of China Life could also be used in its relative valuation, which is a method of valuing China Life by comparing valuation metrics of similar companies.China Life is currently under evaluation in revenue category among its peers.
China Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0091 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.67 % | |||
| Current Valuation | 1 T | |||
| Shares Outstanding | 20.82 B | |||
| Shares Owned By Insiders | 0.62 % | |||
| Shares Owned By Institutions | 93.60 % | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 1.25 X | |||
| Revenue | 829.26 B | |||
| Gross Profit | 123.66 B | |||
| EBITDA | 93.15 B | |||
| Net Income | 21.11 B | |||
| Total Debt | 5.42 T | |||
| Book Value Per Share | 20.05 X | |||
| Cash Flow From Operations | 388.23 B | |||
| Earnings Per Share | 3.10 X | |||
| Price To Earnings To Growth | 1.18 X | |||
| Target Price | 36.74 | |||
| Number Of Employees | 100 K | |||
| Beta | 0.68 | |||
| Market Capitalization | 1.01 T | |||
| Total Asset | 5.89 T | |||
| Retained Earnings | 201.33 B | |||
| Net Asset | 5.89 T | |||
| Last Dividend Paid | 0.43 |
About China Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Life Insurance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Life Insurance based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
China Life financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Life security.